Sort
15,273 grants matching “antimicrobial resistance”
SBIR Phase I: HaloFilm – a spray-on, rechargeable, reapplicable antimicrobial coating
$225,000Mingyu Qiao · Halomine Inc. · · FY2020 · TIP
Rethinking the barrier: How a Gram-negative bacterium alters its surface to become multidrug resistant
$225,000Michael Stephen Trent · University Of Georgia · R21 · FY2015 · AI
SBIR Phase I: Multichannel Resonators Enabling A Phenotypic Point Of Care Infectious Disease Diagnostic
$225,000Danielle France · Microbial Pulse Diagnostics, Llc · · FY2019 · TIP
SBIR Phase I: Tunable Mechanical and Functional Properties of Peptide Films
$225,000Manav Mehta · Gel4med · · FY2019 · TIP
Gonococcal interactions with human polymorphonuclear leukocytes
$225,000Alison K Criss · University Of Virginia · R00 · FY2010 · TW
Ultrathin dissolvable antibiofilm wound contact dressing with silver and gallium
$224,999Ankit Agarwal · Imbed Biosciences, Inc. · R43 · FY2018 · AR
LIGAND MAGNETO KIT FOR FAST MODULAR BACTERIA COLLECTION
$224,997Yang Xu · Luna Innovations, Inc. · N43 · FY2015 · AI
Continuous Production of Organic Peroxyacid Antimicrobial Agents for Wound Care Using a Selective Plasma Oxidation Reactor
$224,983Jessica Joslin · Symbios Technologies, Inc · R43 · FY2016 · GM
SBIR Phase I: Integration of innovative materials into a modular system of semi-permanent construction.
$224,975Gustavo Santander · Green Magic Homes, Inc. · · FY2020 · TIP
Targeting the outer membrane protein translocation pathways
$224,968Stephen Lory · Harvard Medical School · R21 · FY2012 · AI
Targeted Antimicrobial Treatment of Acne Vulgaris by Engineered High Molecular Weight Contractile Nanotubes
$224,962James K. Wang · Dermalytica, Inc. · R43 · FY2015 · AR
Whole-Cell Vaccine Development for MRSA
$224,957Stephen Jeffrey Dollery · Biological Mimetics, Inc. · R43 · FY2019 · AI
Development of Therapeutics to Treat Candida albicans Biofilm Infections
$224,956Clarissa Jane Nobile · Biosynesis, Inc. · R41 · FY2015 · AI
Computational Genomics of Signal Transduction
$224,952Georgia Institute Of Technology · R01 · FY2004 · GM
An innovative metabolic engineering strategy for the discovery of novel macrolide antibiotics
$224,910Jeffrey David Kittendorf · Alluvium Biosciences, Inc. · R43 · FY2016 · GM
Evaluation of the iSeq platform for E. coli pathotyping
$224,906Laura Brunengraber Goodman · Cornell University · U18 · FY2019 · FD
A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans
$224,868Chengcang Charles Wu · Intact Genomics, Inc. · R43 · FY2016 · AT
Mechanisms of antibiotic efflux in Campylobacter
$224,840Iowa State University · R01 · FY2004 · DK
Mechanisms of antibiotic efflux in Campylobacter
$224,840Iowa State University · R01 · FY2005 · DK
Mechanisms of antibiotic efflux in Campylobacter
$224,840Iowa State University · R01 · FY2003 · DK
SBIR Phase I: Exploration of Plasma Activated Water Systems in the Dairy Industry
$224,828Cable Durham · Ozonovation Corp · · FY2019 · TIP
Infection Resistant Hemodialysis Access Graft
$224,815Andrew Marshall · Healionics Corporation · R43 · FY2019 · DK
New insights into early T cell protection during acute toxoplasmosis
$224,807Eric Y Denkers · University Of New Mexico · R21 · FY2022 · AI
A New Tool to Rapidly Diagnose Sepsis using Flow Imaging Microscopy and Machine Learning
$224,803Christopher Peter Calderon · Ursa Analytics, Inc. · R43 · FY2020 · EB
Artificial Urethral Sphincter for Control of Urinary Incontinence in Pediatric Patients
$224,771Atul Varadhachary · Fannin Partners, Llc · R43 · FY2019 · DK